Avalo Therapeutics Officer Stock Disposition

This Form 4 filing reports that Paul Varki, Chief Legal Officer of Avalo Therapeutics, Inc., disposed of 1,081 shares of common stock on June 10, 2026, at a price of $13.10 per share. Following this transaction, Varki holds 32,576 shares directly, which includes 5,723 shares acquired through the company's Employee Stock Purchase Plan. The filing represents a routine insider transaction disclosure required by SEC regulations for corporate officers and directors. The transaction code "F" indicates it was an open market transaction, and "D" designates a disposition of shares. The filing was signed by an attorney-in-fact on June 12, 2026.